Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
01/27/2023 | RVL Pharmaceuticals plc | OSMT | Other (disposition) | Ordinary Shares | 1M | $0.00 | $0 | By Avista Capital investment fund | 01/27/2023 |
08/08/2022 | RVL Pharmaceuticals plc | OSMT | Purchase | Ordinary Shares | 8M | $1.55 | $12.4M | By Avista Capital investment fund | 08/08/2022 |
11/20/2020 | RVL Pharmaceuticals plc | OSMT | Other (disposition) | Ordinary Shares | 4.9M | $0.00 | $0 | By Avista Capital investment fund | 11/20/2020 |
06/10/2020 | OptiNose, Inc. | OPTN | Grant | Stock Option (Right to Buy) | 14.4k | $5.65 | $81.6k | | 06/10/2020 |
01/13/2020 | RVL Pharmaceuticals plc | OSMT | Purchase | Ordinary Shares | 1.2M | $5.00 | $6.2M | By Avista Capital investment fund | 01/13/2020 |
11/25/2019 | OptiNose, Inc. | OPTN | Sale | Common Stock | 70.8k | $9.17 | $648.5k | See footnote | 11/25/2019 |
11/25/2019 | OptiNose, Inc. | OPTN | Sale | Common Stock | 291.5k | $9.17 | $2.7M | See footnote | 11/25/2019 |
11/25/2019 | OptiNose, Inc. | OPTN | Sale | Common Stock | 887.7k | $9.17 | $8.1M | See footnote | 11/25/2019 |
06/06/2019 | OptiNose, Inc. | OPTN | Grant | Stock Option (Right to Buy) | 14.4k | $6.60 | $95.3k | | 06/06/2019 |
06/11/2018 | OptiNose, Inc. | OPTN | Sale | Common Stock | 2M | $20.92 | $42.7M | See footnote | 06/11/2018 |
06/11/2018 | OptiNose, Inc. | OPTN | Sale | Common Stock | 670.5k | $20.92 | $14M | See footnote | 06/11/2018 |
06/11/2018 | OptiNose, Inc. | OPTN | Sale | Common Stock | 162.8k | $20.92 | $3.4M | See footnote | 06/11/2018 |
06/07/2018 | OptiNose, Inc. | OPTN | Grant | Stock Option (Right to Buy) | 14.4k | $22.50 | $324.9k | | 06/07/2018 |
10/17/2017 | OptiNose, Inc. | OPTN | Conversion | Common Stock | 962.7k | $0.00 | $0 | By Avista Capital investment fund | 10/17/2017 |
10/17/2017 | OptiNose, Inc. | OPTN | Conversion | Series C Convertible Preferred Stock | 914.9k | $0.00 | $0 | By Avista Capital investment fund | 10/17/2017 |
10/17/2017 | OptiNose, Inc. | OPTN | Conversion | Series C Convertible Preferred Stock | 222.1k | $0.00 | $0 | By Avista Capital investment fund | 10/17/2017 |
10/17/2017 | OptiNose, Inc. | OPTN | Conversion | Series C-1 Convertible Preferred Stock | 825k | $0.00 | $0 | By Avista Capital investment fund | 10/17/2017 |
10/17/2017 | OptiNose, Inc. | OPTN | Conversion | Series C-1 Convertible Preferred Stock | 270.9k | $0.00 | $0 | By Avista Capital investment fund | 10/17/2017 |
10/17/2017 | OptiNose, Inc. | OPTN | Conversion | Series C-1 Convertible Preferred Stock | 65.8k | $0.00 | $0 | By Avista Capital investment fund | 10/17/2017 |
10/17/2017 | OptiNose, Inc. | OPTN | Conversion | Series C-2 Convertible Preferred Stock | 354.9k | $0.00 | $0 | By Avista Capital investment fund | 10/17/2017 |
10/17/2017 | OptiNose, Inc. | OPTN | Conversion | Series C-2 Convertible Preferred Stock | 116.5k | $0.00 | $0 | By Avista Capital investment fund | 10/17/2017 |
10/17/2017 | OptiNose, Inc. | OPTN | Conversion | Series C-2 Convertible Preferred Stock | 28.3k | $0.00 | $0 | By Avista Capital investment fund | 10/17/2017 |
10/17/2017 | OptiNose, Inc. | OPTN | Conversion | Series D Convertible Preferred Stock | 216.2k | $0.00 | $0 | By Avista Capital investment fund | 10/17/2017 |
10/17/2017 | OptiNose, Inc. | OPTN | Conversion | Series D Convertible Preferred Stock | 216.2k | $0.00 | $0 | By Avista Capital investment fund | 10/17/2017 |
10/17/2017 | OptiNose, Inc. | OPTN | Conversion | Series D Convertible Preferred Stock | 17.2k | $0.00 | $0 | By Avista Capital investment fund | 10/17/2017 |
10/17/2017 | OptiNose, Inc. | OPTN | Conversion | Series C Convertible Preferred Stock | 2.8M | $0.00 | $0 | By Avista Capital investment fund | 10/17/2017 |
10/17/2017 | OptiNose, Inc. | OPTN | Grant | Common Stock | 887.7k | $16.00 | $14.2M | By Avista Capital investment fund | 10/17/2017 |
10/17/2017 | OptiNose, Inc. | OPTN | Grant | Common Stock | 291.5k | $16.00 | $4.7M | By Avista Capital investment fund | 10/17/2017 |
10/17/2017 | OptiNose, Inc. | OPTN | Grant | Common Stock | 70.8k | $16.00 | $1.1M | By Avista Capital investment fund | 10/17/2017 |
10/17/2017 | OptiNose, Inc. | OPTN | Conversion | Common Stock | 12.1M | $0.00 | $0 | By Avista Capital investment fund | 10/17/2017 |
10/17/2017 | OptiNose, Inc. | OPTN | Conversion | Common Stock | 4M | $0.00 | $0 | By Avista Capital investment fund | 10/17/2017 |
03/17/2017 | Lantheus Holdings, Inc. | LNTH | Sale | Common Stock | 840k | $12.20 | $10.2M | See footnote | 03/17/2017 |
03/17/2017 | Lantheus Holdings, Inc. | LNTH | Sale | Common Stock | 450.7k | $12.20 | $5.5M | See footnote | 03/17/2017 |
03/17/2017 | Lantheus Holdings, Inc. | LNTH | Sale | Common Stock | 1.7M | $12.20 | $20.9M | See footnote | 03/17/2017 |
11/21/2016 | Lantheus Holdings, Inc. | LNTH | Sale | Common Stock | 700k | $9.00 | $6.3M | See footnote | 11/21/2016 |
|